Cargando…

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

BACKGROUND: The current study was conducted to examine the activity of a docetaxel/oxaliplatin (DocOx) combination as second line treatment for advanced pancreatic ductal adenocarcinoma (Trial registration: NCT00690300. Registered June 2, 2008) METHODS: DocOx is a prospective, multi-center, single a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714522/ https://www.ncbi.nlm.nih.gov/pubmed/26772812 http://dx.doi.org/10.1186/s12885-016-2052-4

Ejemplares similares

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
por: Ettrich, Thomas J., et al.
Publicado: (2018)

Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
por: Perkhofer, L., et al.
Publicado: (2019)

Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109)
por: Kurreck, A., et al.
Publicado: (2020)

Terahertz Electromagnetic Fields (0.106 THz) Do Not Induce Manifest Genomic Damage In Vitro
por: Hintzsche, Henning, et al.
Publicado: (2012)

MICB0106 gene polymorphism is associated with ulcerative colitis in central China
por: Li, Yi, et al.
Publicado: (2009)

Protocol for MInimizing the Risk of Metachronous Adenomas of the CoLorectum with Green Tea Extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population
por: Stingl, Julia C, et al.
Publicado: (2011)

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205
por: Hoehler, T, et al.
Publicado: (2013)

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
por: Ormanns, Steffen, et al.
Publicado: (2014)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy
por: Sturm, Niklas, et al.
Publicado: (2022)

Aios in coronatijd
por: Maria Greijn, Claudia, et al.
Publicado: (2020)

OA01.06. A successful clinical case study of Asthenozoospermia + Oligozoospermia
por: Nadargi, Raghavendra
Publicado: (2013)

Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacter pylori
por: Yang, Kai‐Yuan, et al.
Publicado: (2021)

Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2020)

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)
por: Tintelnot, Joseph, et al.
Publicado: (2023)

EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
por: Boeck, S, et al.
Publicado: (2013)

Correction: Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer – translational results from the AIO-PK0104 Phase 3 study
por: Guenther, Michael, et al.
Publicado: (2021)

Doc
Publicado: (1894)

Posthumous tribute to Professor Bernardo Gontijo(): (08.06.1952 – 01.06-2022)
por: Vale, Everton Carlos Siviero do, et al.
Publicado: (2023)

S-1 maintenance therapy in Caucasian patients with metastatic esophagogastric adenocarcinoma–final results of the randomized AIO MATEO phase II trial
por: Stocker, G., et al.
Publicado: (2023)

Untargeted Microbial Exometabolomics and Metabolomics Analysis of Helicobacter pylori J99 and jhp0106 Mutant
por: Kao, Cheng-Yen, et al.
Publicado: (2021)

Beam Doc
por: Yenphraphai, Jiraphon
Publicado: (2018)

AIOS proceedings: A response
por: Rajendran, Babu
Publicado: (2009)

19. AIO-Herbstkongress 2022
Publicado: (2023)

P01.06. The effect of bee venom pharmacopuncture therapy in a neuropathic pain rat model
por: Kwon, Y, et al.
Publicado: (2012)

PA01.06. Clinico comparative study of shodhan purvak shaman & shaman chikitsa in management of aamvata
por: Nagpal, Swati
Publicado: (2012)

Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
por: Sturm, Niklas, et al.
Publicado: (2022)

Medical Treatment of Gastroenteropancreatic Neuroendocrine Tumors
por: Rinke, Anja, et al.
Publicado: (2012)

Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study
por: Müller, Martin, et al.
Publicado: (2015)

Poland's environmental docs.
Publicado: (1994)

WhatsApp Doc?
por: Gould, Georgina, et al.
Publicado: (2016)

Rubaiyat of Doc Sifers
Publicado: (1898)

Significantly improved precision of cell migration analysis in time-lapse video microscopy through use of a fully automated tracking system
por: Huth, Johannes, et al.
Publicado: (2010)

OA01.06. A clinical evaluation of langlimool (gloriosa superba) on inderlupta w.s.r. to alopacia areata
por: Sharma, Anita, et al.
Publicado: (2012)

Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021)

Trends and Challenges in AIoT/IIoT/IoT Implementation
por: Hou, Kun Mean, et al.
Publicado: (2023)

Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study
por: Kruger, S.F., et al.
Publicado: (2022)

Google Docs 4 everyone
por: Holzner, Steven, et al.
Publicado: (2009)

Screening Technologies for Target Identification in Pancreatic Cancer
por: Michl, Patrick, et al.
Publicado: (2010)

AIOS Constitution Reforms - Change is the Secret Sauce for Success
por: Honavar, Santosh G
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vuae4kfaoa4rn2p12ediuef21l